High-quality elevations in liver-function ideals were normalized in 67.9 weeks . No patient died because of complications of immune-mediated hepatitis or enterocolitis during the course of the study. Among the 43 patients who received ipilimumab and the 53 patients who received placebo during the maintenance stage, the most typical adverse events were rash , pruritus , diarrhea , nausea , and fatigue . Low-grade boosts in liver-function ideals were noted in 2 patients receiving ipilimumab through the maintenance stage. No high-grade elevations in liver-function ideals were observed among the individuals receiving ipilimumab during the maintenance stage.@dallaspiosana @DallasFireRes_q #DallasEbola pic.twitter. Max Geron October 15, 2014 @DallasFireRes_q Haz-Mat taping off door. Pic.twitter. The Texas Division of State Health Solutions confirmed in a separate statement that medical worker did provide treatment to Thomas Eric Duncan, whom officials make reference to as ‘the index affected person’ and may be the Liberian nationwide who died at Presbyterian on Oct. 8. Duncan was the 1st person to be identified as having Ebola on U.S.